Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06AZH
|
|||
Former ID |
DIB003341
|
|||
Drug Name |
B-220
|
|||
Synonyms |
2,3-dimethyl-6-(dimethylaminoethyl)-9-hydroxy-6H-indolo-[2,3-b]quinoxaline; 9-OH-B-220
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Autoimmune diabetes [ICD-11: 5A10] | Terminated | [1] | |
Company |
OxyPharma AB
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H22N4
|
|||
Canonical SMILES |
CC1=CC2=C(C=C1C)N=C3C(=N2)C4=CC=CC=C4N3CCN(C)C
|
|||
InChI |
1S/C20H22N4/c1-13-11-16-17(12-14(13)2)22-20-19(21-16)15-7-5-6-8-18(15)24(20)10-9-23(3)4/h5-8,11-12H,9-10H2,1-4H3
|
|||
InChIKey |
FPLSGFJELWCFTH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 112228-65-6
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021876) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.